Licorice Extract Block (Powder),China price supplier

Qinghai Lake Pharmaceutical Co., Ltd. was founded in 1987,the company is one of the three national fixed-point production enterprises of the ephedrine. QHL
Pharmaceuticals is based on abundant licorice resources inQinghai, Xinjiang and Central Asia and commits to the deep research and development of licorice extracts. The total assets of company reached 467 million RMB. There are over 300 existing staffs and the R&D team riches in technical talents, including 50 professional employees and 10 of them with PHD degree. In order to integrate the superior licorice resources in Qinghai, Xinjiang, Afghanistan, four licorice crude products processing factories have been set up with more than 100 thousand acres of licorice planting base. In 2014, the company invested 5 million U.S. dollars in Afghanistan through the construction of the Glycyrrhizic Acid production line, which has the annual output of 2,000T. It is able to guarantee the supply of raw materials for QHL Pharmaceuticals. High quality licorice extracts from QHL
Pharmaceuticals are widely used in cosmetic, food, tobacco industries and medicine area. Additionally, the company’s R&D team partners with many scientific institutions to
develop new anti-cancer drugs by isolating and purifying the active components of licorice. For the past few years, QHL Pharmaceuticals has successfully isolated 70 monomeric compounds from 420 kinds of working contents in licorice and it will continue as always to increase investment in research and development. At the same time, the company devotes itself to developing consumer products of licorice, aiming to create and identify the new branding—YIXITANG with licorice as the core of thishealthy industry chain. A series of products, for instance Chinese herbal medicine, health tea, oral-care products and other consumer products will gradually enter into the market.